Giant Ventures Global Llp — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Ataraxis develops AI foundation models that analyze multi-modal patient data, including pathology slide images, to assess cancer aggressiveness and predict recurrence risk and treatment response.
AI & Machine LearningBiotechHealthtechNew York, US
Jan Witowski(Co-founder (physician-scientist))inKrzysztof Geras(Co-founder)Jan Witowski MD PhD(Founder)in
BoardKrish Ramadural(Director)Rohan Ganeshananthan(Director)
Co-investorsAIX VenturesFloating PointObvious VenturesTranspose Platform ManagementBertelsmann InvestmentsFounders Fund
Invert provides infrastructure and intelligence software that connects bioprocess equipment and data sources for pharmaceutical and biologics companies, enabling faster process development and manufacturing through integrated data platforms and digital twin capabilities.
AI & Machine LearningBiotechData & InfrastructureEnterprise SoftwareHealthtechSan Francisco, US
Martin T. Permin(Founder)inHolger Thorup(Founder)inSam Cates(Director)
BoardChristian Tang-Jespersen(Director)in
Co-investorsACME CapitalCathexis VenturesY CombinatorTechNexus Venture Collaborative
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.